Junji Uchino

6.8k total citations
170 papers, 2.9k citations indexed

About

Junji Uchino is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Junji Uchino has authored 170 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Oncology, 67 papers in Pulmonary and Respiratory Medicine and 40 papers in Surgery. Recurrent topics in Junji Uchino's work include Lung Cancer Treatments and Mutations (52 papers), Lung Cancer Research Studies (34 papers) and Cancer Immunotherapy and Biomarkers (30 papers). Junji Uchino is often cited by papers focused on Lung Cancer Treatments and Mutations (52 papers), Lung Cancer Research Studies (34 papers) and Cancer Immunotherapy and Biomarkers (30 papers). Junji Uchino collaborates with scholars based in Japan, United States and China. Junji Uchino's co-authors include Koichi Takayama, Tadaaki Yamada, Yoshiko Kaneko, Yusuke Chihara, Masahiro Iwasaku, Yuki Katayama, Nobuyo Tamiya, Takayuki Shimamoto, Naoki Sato and Yoshie Une and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Hepatology.

In The Last Decade

Junji Uchino

161 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junji Uchino Japan	25	1.2k	792	726	526	457	170	2.9k
Kosuke Mima Japan	35	1.4k 1.2×	471 0.6×	891 1.2×	1.4k 2.6×	351 0.8×	131	3.3k
Sung Noh Hong South Korea	27	1.0k 0.9×	946 1.2×	985 1.4×	443 0.8×	466 1.0×	184	2.9k
Chul Won Jung South Korea	37	1.5k 1.2×	682 0.9×	534 0.7×	1.5k 2.9×	947 2.1×	245	5.0k
Yasunobu Abe Japan	30	922 0.8×	318 0.4×	908 1.3×	738 1.4×	586 1.3×	163	3.5k
Tetsuya Mine Japan	35	1.0k 0.8×	1.0k 1.3×	2.5k 3.4×	1.4k 2.6×	236 0.5×	239	4.6k
Claudio Avellini Italy	36	503 0.4×	623 0.8×	1.6k 2.2×	483 0.9×	344 0.8×	115	3.7k
Giuseppe Sica Italy	36	771 0.6×	400 0.5×	1.2k 1.6×	980 1.9×	275 0.6×	139	4.0k
Osamu Kimura Japan	30	500 0.4×	940 1.2×	1.2k 1.7×	501 1.0×	155 0.3×	201	3.0k
Peter Kienle Germany	34	1.6k 1.3×	1.0k 1.3×	1.9k 2.6×	334 0.6×	479 1.0×	108	3.5k
Francesco Perfumo Italy	32	676 0.6×	357 0.5×	354 0.5×	684 1.3×	315 0.7×	145	3.6k

Countries citing papers authored by Junji Uchino

Since Specialization

Citations

This map shows the geographic impact of Junji Uchino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Uchino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Uchino more than expected).

Fields of papers citing papers by Junji Uchino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Uchino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Uchino. The network helps show where Junji Uchino may publish in the future.

Co-authorship network of co-authors of Junji Uchino

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Uchino. A scholar is included among the top collaborators of Junji Uchino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Uchino. Junji Uchino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Honma, T., Masao Takagi, Junji Uchino, & Ken Tsuchiya. (2024). The role of clinical engineers in dialysis therapy in Japan. Renal Replacement Therapy. 10(1).

Iwasaku, Masahiro, Junji Uchino, Takahiro Yamada, et al.. (2023). Prophylactic treatment of dacomitinib‐induced skin toxicities in epidermal growth factor receptor‐mutated non–small‐cell lung cancer: A multicenter, Phase II trial. Cancer Medicine. 12(14). 15117–15127. 3 indexed citations

Yamada, Tadaaki, Yasuhiro Gotô, Hiroshi Tanaka, et al.. (2023). A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study. European Journal of Cancer. 195. 113373–113373. 8 indexed citations

Tanimura, Keiko, Junji Uchino, Hideharu Kimura, et al.. (2023). Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases: A Multicenter, Open-Label Single-Arm Phase II Trial. The Oncologist. 28(6). 551–e454. 6 indexed citations

Naito, Tateaki, Junji Uchino, Toru Kojima, et al.. (2022). A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in patients with cancer cachexia and low body mass index. Cancer. 128(10). 2025–2035. 31 indexed citations

Morimoto, Kenji, Junji Uchino, Takashi Yokoi, et al.. (2021). Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study. OncoImmunology. 10(1). 1950411–1950411. 33 indexed citations

Yamada, Tadaaki, Kenji Morimoto, Akira Nakao, et al.. (2021). Impact of maintenance therapy following induction immunochemotherapy for untreated advanced non-small cell lung cancer patients. Journal of Cancer Research and Clinical Oncology. 148(11). 2985–2994. 1 indexed citations

Tanimura, Keiko, Tadaaki Yamada, Mano Horinaka, et al.. (2021). Inhibition of c-Jun N-terminal kinase signaling increased apoptosis and prevented the emergence of ALK-TKI-tolerant cells in ALK-rearranged non-small cell lung cancer. Cancer Letters. 522. 119–128. 12 indexed citations

Asano, Mai, Junji Uchino, Yoshie Morimoto, et al.. (2020). Endocrinopathies Associated with Immune Checkpoint Inhibitor Cancer Treatment: A Review. Journal of Clinical Medicine. 9(7). 2033–2033. 20 indexed citations

10.

Morimoto, Kenji, Tadaaki Yamada, Yuki Katayama, et al.. (2020). Impact of preexisting antinuclear antibodies on combined immunotherapy and chemotherapy in advanced non-small cell lung cancer patients. Medical Oncology. 37(12). 111–111. 12 indexed citations

11.

Yamada, Tadaaki, Junji Uchino, Yusuke Chihara, et al.. (2020). Rationale and design of a phase II trial of durvalumab treatment in patients with NSCLC ineligible for stage III chemoradiotherapy following radiation monotherapy (SPIRAL-RT study). Therapeutic Advances in Medical Oncology. 12. 3863542881–3863542881. 7 indexed citations

12.

Onoi, Keisuke, Yusuke Chihara, Junji Uchino, et al.. (2020). Immune Checkpoint Inhibitors for Lung Cancer Treatment: A Review. Journal of Clinical Medicine. 9(5). 1362–1362. 117 indexed citations

13.

Yamada, Tadaaki, Yuki Katayama, Akihiro Yoshimura, et al.. (2019). Retrospective efficacy analysis of immune checkpoint inhibitors in patients with EGFR‐mutated non‐small cell lung cancer. Cancer Medicine. 8(4). 1521–1529. 78 indexed citations

14.

Imabayashi, Tatsuya, Junji Uchino, Akihiro Yoshimura, et al.. (2019). Safety and Usefulness of Cryobiopsy and Stamp Cytology for the Diagnosis of Peripheral Pulmonary Lesions. Cancers. 11(3). 410–410. 31 indexed citations

15.

Katayama, Yuki, Tadaaki Yamada, Keiko Tanimura, et al.. (2019). Impact of bowel movement condition on immune checkpoint inhibitor efficacy in patients with advanced non‐small cell lung cancer. Thoracic Cancer. 10(3). 526–532. 16 indexed citations

16.

Nishioka, Naoya, Junji Uchino, Yuki Katayama, et al.. (2019). Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer. Journal of Clinical Medicine. 8(4). 450–450. 75 indexed citations

17.

Yoshimura, Akihiro, Tadaaki Yamada, Taisuke Tsuji, et al.. (2019). Prognostic impact of pleural effusion in EGFR‐mutant non‐small cell lung cancer patients without brain metastasis. Thoracic Cancer. 10(3). 557–563. 8 indexed citations

18.

Yoshimura, Akihiro, Tadaaki Yamada, Takayuki Takeda, et al.. (2019). Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation. Cancers. 11(3). 365–365. 11 indexed citations

19.

Nishioka, Naoya, Tadaaki Yamada, Yuki Katayama, et al.. (2018). Successful sequential treatment of refractory tumors caused by small cell carcinoma transformation and EGFR-T790M mutation diagnosed by repeated genetic testing in a patient with lung adenocarcinoma harboring epidermal growth factor receptor mutations: A case report. Respiratory Medicine Case Reports. 25. 261–263. 7 indexed citations

20.

Okouchi, Yasumitsu, et al.. (1988). Hypothermic preservation of the rat liver assessed by orthotopic transplantation. III. Improved functional recovery with isotonic citrate solution and a stable prostacyclin analogue.. PubMed. 46(4). 626–8. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact